4SC AG: 4SC publishes Q1 2024 report
4SC AG (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients suffering with advanced-stage c…
4SC AG (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients suffering with advanced-stage c…
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
Removes the requirement to conduct paediatric clinical studies when the development of the medicine is not needed or is…
TÜV SÜD Danmark ApS today received its designation as Notified Body 2443 under Medical Device Regulation 2017/745 by the…
4SC AG (4SC, FSE Prime Standard: VSC) today published its financial results for the financial year ended 31 December 202…
Group sales rise to CHF 577.3 million (+8.6%) in 2023. EBITDA at CHF 166.7 million (+3.9%) with a margin of 28.9%. Stro…
4SC AG (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients suffering with advanced-stage c…
For the next three years, BASF will help INEOS Automotive build its global body and paint program focusing on the highes…
Aktuelle Apotheken-Highlights in Deutschland: Von Risikominimierung bei Insolvenz von Abrechnungszentren bis hin zur Kon…
Die Medicines and Healthcare Products Regulatory Agency (MHRA), die Zulassungsbehörde für Arzneimittel in Großbritannien…